Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Incyte Corp (NQ: INCY )

86.64 USD -0.38 (-0.44%)
Official Closing Price Updated: 4:46 PM EDT, Oct 30, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,105,300
Open 86.55
Bid (Size) 78.98 (1)
Ask (Size) 94.00 (1)
Prev. Close 87.02
Today's Range 83.44 - 86.84
52wk Range 62.48 - 110.36
Shares Outstanding 211,969,163
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Patients with Alopecia Areata
- Data support baricitinib's ongoing Phase 3 program and potential to be the first approved medicine for people living with alopecia areata (AA) 
From PR Newswire
Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen
Further results from NIAID-sponsored ACTT-2 Trial Presented Today 
From PR Newswire

Performance

YTD
+0.78%
+0.78%
1 Month
-3.45%
-3.45%
3 Month
-12.27%
-12.27%
6 Month
-10.96%
-10.96%
1 Year
+3.24%
+3.24%

More News

Read More
Incyte Ranked Second Among Science Magazine’s 2020 Top Biopharma Employers
From Business Wire News Releases
Clinical Trials Delivering New Optimism in Fight Against Triple-Negative Breast Cancer
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Clinical Trials Delivering New Optimism in Fight Against Triple-Negative Breast Cancer
From PR Newswire
Pooled Results from Incyte’s TRuE-AD1 and TRuE-AD2 Atopic Dermatitis Studies of Ruxolitinib Cream Show Clinically Meaningful Improvements in Patient-Reported Quality of Life Assessments
From Business Wire News Releases
Incyte to Report Third Quarter Financial Results
From Business Wire News Releases
Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics
From Business Wire News Releases
Investors Are Scrambling To Get Ahead Of The Oncology Drug Market Boom; 1 Company Could Revolutionize The Industry
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Zai Lab Starts Trial of Anti-PD1 Antibody for Endometrial Cancer
From ChinaBio® Today
PG&E Larger Than S&P 500 Component Incyte
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]